323 related articles for article (PubMed ID: 21557776)
21.
Ram-Wolff C; Vercellino L; Brice P; La Selva R; Bagot M
Eur J Dermatol; 2017 Oct; 27(5):496-504. PubMed ID: 28721937
[TBL] [Abstract][Full Text] [Related]
22. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.
El-Galaly TC; d'Amore F; Mylam KJ; de Nully Brown P; Bøgsted M; Bukh A; Specht L; Loft A; Iyer V; Hjorthaug K; Nielsen AL; Christiansen I; Madsen C; Johnsen HE; Hutchings M
J Clin Oncol; 2012 Dec; 30(36):4508-14. PubMed ID: 23150698
[TBL] [Abstract][Full Text] [Related]
23. Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies.
Khong PL; Pang CB; Liang R; Kwong YL; Au WY
Ann Hematol; 2008 Aug; 87(8):613-21. PubMed ID: 18509641
[TBL] [Abstract][Full Text] [Related]
24. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN
Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940
[TBL] [Abstract][Full Text] [Related]
25. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
[TBL] [Abstract][Full Text] [Related]
26. Utility of baseline, interim and end-of-treatment
Chang Y; Fu X; Sun Z; Xie X; Wang R; Li Z; Zhang X; Sheng G; Zhang M
Sci Rep; 2017 Jan; 7():41057. PubMed ID: 28117395
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic value of pretreatment PET/CT in extranodal natural killer/T-cell lymphoma: a retrospective multicenter study.
Yu M; Chen Z; Wang Z; Fang X; Li X; Ye H; Lin T; Huang H
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8863-8875. PubMed ID: 37148293
[TBL] [Abstract][Full Text] [Related]
28. Extranodal malignant lymphoma: detection with FDG PET versus CT.
Moog F; Bangerter M; Diederichs CG; Guhlmann A; Merkle E; Frickhofen N; Reske SN
Radiology; 1998 Feb; 206(2):475-81. PubMed ID: 9457202
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma.
Ding JJ; Chen YL; Zhou SH; Zhao K
J Int Med Res; 2018 Dec; 46(12):4920-4929. PubMed ID: 30328364
[TBL] [Abstract][Full Text] [Related]
30. [Non-Hodgkin's lymphoma staging: a prospective study of the value of positron emission tomography/computed tomography (PET/CT) versus PET and CT].
Rodríguez-Vigil Junco B; Gómez León N; Pinilla Fernández I; del Campo L; Hernández Maraver D; Coya J
Med Clin (Barc); 2011 Oct; 137(9):383-9. PubMed ID: 21703647
[TBL] [Abstract][Full Text] [Related]
31. The value of routine bone marrow examination in patients with extranodal NK/T-cell lymphoma staged with PET/CT.
Yang Y; Wang JJ; Zhao RZ; Huang C; Shi GQ; Zheng H; Tang TL; Liao SQ; Chen JH; Shen JZ; Liu TB; Xu BH; Zhang YJ
Cancer; 2022 Nov; 128(22):3943-3950. PubMed ID: 36181669
[TBL] [Abstract][Full Text] [Related]
32. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
Kumar R; Xiu Y; Zhuang HM; Alavi A
Br J Dermatol; 2006 Aug; 155(2):357-63. PubMed ID: 16882175
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of pretreatment positron emission tomography/computed tomography in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.
Bai B; Huang HQ; Cai QC; Fan W; Wang XX; Zhang X; Lin ZX; Gao Y; Xia YF; Guo Y; Cai QQ; Jiang WQ; Lin TY
Med Oncol; 2013 Mar; 30(1):339. PubMed ID: 23329306
[TBL] [Abstract][Full Text] [Related]
34. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
35. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma.
Sakurai M; Toyama T; Kikuchi T; Kato J; Shimizu T; Koda Y; Karigane D; Yamane Y; Abe R; Yamazaki R; Nakazato T; Nakahara T; Jinzaki M; Okamoto S; Mori T
Int J Hematol; 2018 Feb; 107(2):194-200. PubMed ID: 28994017
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma.
Pinilla I; Gómez-León N; Del Campo-Del Val L; Hernandez-Maraver D; Rodríguez-Vigil B; Jover-Díaz R; Coya J
Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):567-75. PubMed ID: 21150860
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
Najjar F; Hustinx R; Jerusalem G; Fillet G; Rigo P
Cancer Biother Radiopharm; 2001 Aug; 16(4):297-304. PubMed ID: 11603000
[TBL] [Abstract][Full Text] [Related]
38. Utility of PET/CT in the diagnosis and staging of extranodal natural killer/T-cell lymphoma: a systematic review and meta-analysis.
Zhou X; Lu K; Geng L; Li X; Jiang Y; Wang X
Medicine (Baltimore); 2014 Dec; 93(28):e258. PubMed ID: 25526450
[TBL] [Abstract][Full Text] [Related]
39. Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma.
Carrillo-Cruz E; Marín-Oyaga VA; Solé Rodríguez M; Borrego-Dorado I; de la Cruz Vicente F; Quiroga Cantero E; Manzanares Pérez M; Capote FJ; Ramírez Sánchez MJ; Espigado Tocino I; Pérez-Vega H; Vázquez-Albertino R; Pérez-Simón JA
Eur J Haematol; 2015 Jan; 94(1):23-30. PubMed ID: 24520874
[TBL] [Abstract][Full Text] [Related]
40. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
